Showing results (301-310 of 322) with videos related to

Sort By:
Pageof 33
Hemasphere|April 20, 2026
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complicationsFrancesco Mannelli, Francesca Crupi, Sara Bencini, et al.
The New England Journal of Medicine|October 11, 2018
Classification and Personalized Prognosis in Myeloproliferative NeoplasmsJacob Grinfeld, Jyoti Nangalia, E Joanna Baxter, et al.
Blood|September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyureaAbdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
Haematologica|August 6, 2013
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.
Blood|March 5, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosisBarbara Mora, Francesca Palandri, Paola Guglielmelli, et al.
Blood|August 8, 2024
Proposals for revised International Working Group-European LeukemiaNet criteria for anemia response in myelofibrosisAyalew Tefferi, Giovanni Barosi, Francesco Passamonti, et al.
American Journal of Hematology|April 11, 2016
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patientsLisa Pieri, Patrizia Bonadonna, Chiara Elena, et al.
Pageof 33